WTX-330

N/A

Report date: 2025/04/23 20:01:04

Base Information

Drug NameWTX-330
Drug Alias NameWTX-330 Interleukin-12 (IL-12) INDUKINETM moleculeWTX-330
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-12 replacements
TargetsInterleukin-12
Therapy Area/IndicationsSolid tumoursLymphoma, Non-HodgkinNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesWerewolf Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesWerewolf Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma, Non-HodgkinNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A